13F HOLDINGS REPORT
SUPERSTRING CAPITAL MANAGEMENT LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001931118-24-000009
Total Value
$79.3M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CYTOKINETICS INC | CYTK | 187,633 | $10.2M | 12.81% |
| 2 | LEGEND BIOTECH CORP | LEGN | 154,665 | $6.9M | 8.64% |
| 3 | TERNS PHARMACEUTICALS INC | TERN | 956,542 | $6.5M | 8.21% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 219,837 | $5.6M | 7.02% |
| 5 | 89BIO INC | 282559103 | 680,403 | $5.5M | 6.87% |
| 6 | NKARTA INC | NKTX | 875,999 | $5.2M | 6.53% |
| 7 | ZAI LAB LTD | ZLAB | 215,178 | $3.7M | 4.70% |
| 8 | KEROS THERAPEUTICS INC | KROS | 74,288 | $3.4M | 4.28% |
| 9 | ARCELLX INC | ACLX | 59,133 | $3.3M | 4.11% |
| 10 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 111,133 | $2.9M | 3.64% |
| 11 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 56,468 | $2.6M | 3.22% |
| 12 | BEIGENE LTD | BEIGF | 12,508 | $1.8M | 2.25% |
| 13 | FATE THERAPEUTICS INC | FATE | 497,360 | $1.6M | 2.06% |
| 14 | ALLOGENE THERAPEUTICS INC | ALLO | 689,912 | $1.6M | 2.03% |
| 15 | PYXIS ONCOLOGY INC | PYXS | 484,443 | $1.6M | 2.02% |
| 16 | APOGEE THERAPEUTICS INC | APGE | 36,928 | $1.5M | 1.83% |
| 17 | CYTOMX THERAPEUTICS INC | CTMX | 1,151,518 | $1.4M | 1.77% |
| 18 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 64,213 | $1.2M | 1.55% |
| 19 | TOURMALINE BIO INC | 89157D105 | 95,229 | $1.2M | 1.54% |
| 20 | NOVOCURE LTD | NVCR | 66,892 | $1.1M | 1.44% |
| 21 | SPYRE THERAPEUTICS INC | SYRE | 45,571 | $1.1M | 1.35% |
| 22 | CABALETTA BIO INC | CABA | 139,895 | $1.0M | 1.32% |
| 23 | TANGO THERAPEUTICS INC | TNGX | 115,571 | $991,599 | 1.25% |
| 24 | ALLAKOS INC | 01671P100 | 940,578 | $940,578 | 1.19% |
| 25 | PERSPECTIVE THERAPEUTICS INC | CATX | 87,638 | $873,751 | 1.10% |
| 26 | SAVARA INC | SVRA | 200,000 | $806,000 | 1.02% |
| 27 | BIOMEA FUSION INC | BMEA | 167,110 | $751,995 | 0.95% |
| 28 | KURA ONCOLOGY INC | KURA | 36,242 | $746,223 | 0.94% |
| 29 | ZURA BIO LTD | ZURA | 156,626 | $548,191 | 0.69% |
| 30 | ATYR PHARMA INC | ATYR | 313,028 | $488,324 | 0.62% |
| 31 | PEPGEN INC | PEPG | 29,249 | $466,814 | 0.59% |
| 32 | KARYOPHARM THERAPEUTICS INC | KPTI | 534,485 | $463,719 | 0.58% |
| 33 | EYEPOINT PHARMACEUTICALS INC | EYPT | 37,838 | $329,191 | 0.41% |
| 34 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 261,861 | $306,377 | 0.39% |
| 35 | MERSANA THERAPEUTICS INC | 59045L106 | 110,073 | $221,247 | 0.28% |
| 36 | LAKESHORE BIOPHARMA CO LTD | G9845F109 | 307,920 | $199,501 | 0.25% |
| 37 | COMPASS PATHWAYS PLC | CMPS | 32,497 | $196,282 | 0.25% |
| 38 | SYROS PHARMACEUTICALS INC | 87184Q206 | 37,789 | $194,991 | 0.25% |
| 39 | SPRUCE BIOSCIENCES INC | SPRB | 77,992 | $40,376 | 0.05% |